Longterm Efficacy and Safety of NVP-based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.
Longterm Efficacy and Safety of NVP-based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.
The aim of this trial is to evaluate the safety and virological and immunological efficacy of Viramune® on a background of different antiretroviral drug combinations.
Inclusion criteria:
The inclusion criteria follow the same criteria which are describe in the newest SPC.
Exclusion criteria:
The exclusion criteria follow the same criteria which are describe in the newest SPC.
Lódz, Poland